[Federal Register: November 19, 1999 (Volume 64, Number 223)]
[Notices]
[Page 63324-63325]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19no99-75]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Nonclinical Studies Subcommittee of the Advisory Committee for
Pharmaceutical Science; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
    Name of Committee: Nonclinical Studies Subcommittee of the Advisory
Committee for Pharmaceutical Science
    General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on December 14, 1999, 8:30
a.m. to 5:30 p.m.
    Location: Holiday Inn, The Ballrooms, Two Montgomery Village Ave.,
Gaithersburg, MD.
    Contact Person: Kimberly L. Topper at Topperk@cder.fda.gov or Angie
Whitacre at Whitacrea@cder.fda.gov, Center for Drug Evaluation and
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area), code 12539. Please call the Information Line for up-to-date
information on this meeting.
    Agenda: The subcommittee will discuss collaborative approaches to
scientific research issues of common interest to the pharmaceutical
industry, universities, the public, and FDA. Specific areas of focus
will be in the nonclinical studies areas of: (1) Interspecies
biomarkers of toxicity, (2) high-resolution magnetic imaging, (3)
positron emission tomography imaging, and (4) methods to facilitate
early human assessments.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by December 9,
1999. Oral presentations from the public will be scheduled between
approximately 1 p.m. to 2 p.m. Time allotted for each presentation may
be limited. Those desiring to make formal oral presentations should
notify the contact person before December 9, 1999, and

[[Page 63325]]

submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: November 10, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-30192 Filed 11-18-99; 8:45 am]
BILLING CODE 4160-01-F